This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
PharmD Lives virtual clinical pharmacists provide a proactive, AI-driven MedicationTherapyManagement (MTM) solution that optimizes specialty drug utilization, ensures adherence and reduces unnecessary spending.
Leveraging Telehealth to Expand Practice Income Telehealth technologies present a powerful opportunity to enhance care and boost revenue. Addressing Medication Challenges with Optimization Medication issues such as ADEs and nonadherence are preventable yet costly. Free up staff and physicians to focus on patient care.
MedicationTherapyManagement in geriatric MedicationTherapyManagement (MTM) Is a service provided typically by pharmacists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them.
[1] The Rome IV Diagnostic Criteria (a system developed to classify the functional gastrointestinal disorders) for chronic constipation, states that these symptoms must be present for six months or greater, and must accompany at least 25 percent of bowel movements in the last three months. pylori or low thyroid function is present. [89]
However, the scope and complexity of the proposed rule may present implementation challenges. Standardized templates can help eliminate ambiguities, ensuring that all essential information is presented in an accessible and user-friendly manner. 34 Finally, the NHC emphasizes the importance of empowering beneficiaries through education.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content